International Journal of Antimicrobial Agents
Volume 36, Issue 1 , Pages 50-57 , July 2010

Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites

  • Ruchi Singh

      Affiliations

    • Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi 110029, India
    • Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, CBER, FDA, Bethesda, MD, USA
    • 1 Present address: National Institute of Malaria Research (ICMR), Delhi, India.
    • ,
  • Dhiraj Kumar

      Affiliations

    • Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi 110029, India
    • ,
  • Robert C. Duncan

      Affiliations

    • Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, CBER, FDA, Bethesda, MD, USA
    • ,
  • Hira L. Nakhasi

      Affiliations

    • Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, CBER, FDA, Bethesda, MD, USA
    • ,
  • Poonam Salotra

      Affiliations

    • Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi 110029, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 11 2616 6124; fax: +91 11 2616 6124.

Received 3 October 2009 ,Accepted 3 March 2010.

References 

  1. Alvar J, Yactayo S, Bern C. Leishmaniasis and poverty. Trends Parasitol. 2006;22:552–557
  2. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27:305–318
  3. Sundar S. Drug resistance in Indian visceral leishmaniasis. Trop Med Int Health. 2001;6:849–854
  4. Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, et al. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis. 1999;180:564–567
  5. Singh R, Kumar D, Ramesh V, Negi NS, Singh S, Salotra P. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis. J Infect Dis. 2006;194:302–306
  6. Kumar D, Kulshrestha A, Singh R, Salotra P. In vitro susceptibility of field Isolates of Leishmania donovani to miltefosine and amphotericin B: correlation with sodium antimony glutamate susceptibility and implications for treatment in areas of endemicity. Antimicrob Agents Chemother. 2009;53:835–838
  7. Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M. Unresponsiveness to glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med. 2006;3:e162
  8. Yardley V, Ortuno N, Llanos-Cuentas A, Chappuis F, Doncker SD, Ramirez L, et al. American tegumentary leishmaniasis: is antimonial treatment outcome related to parasite drug susceptibility?. J Infect Dis. 2006;194:1168–1175
  9. Rojas R, Valderrama L, Valderrama M, Varona MX, Ouellette M, Saravia NG. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection. J Infect Dis. 2006;193:1375–1383
  10. Ouellette M, Drummelsmith J, Papadopoulou B. Leishmaniasis: drugs in the clinic, resistance and new developments. Drug Resist Updat. 2004;7:257–266
  11. Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev. 2006;19:111–126
  12. Guimond C, Trudel N, Brochu C, Marquis N, El Fadili A, Peytavi R, et al. Modulation of gene expression in Leishmania drug resistant mutants as determined by targeted DNA microarrays. Nucleic Acids Res. 2003;31:5886–5896
  13. Salotra P, Singh R, Duncan R, Nakhasi H. Microarray based analysis of gene expression in drug resistant Leishmania donovani isolated from Indian patients of Kala azar. In: 15th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 2–5 April 2005, Copenhagen, Denmark. Abstract O204: 47–48.
  14. Singh N, Almeida R, Kothari H, Kumar P, Mandal G, Chatterjee M, et al. Differential gene expression analysis in antimony-unresponsive Indian kala azar (visceral leishmaniasis) clinical isolates by DNA microarray. Parasitology. 2007;134:777–787
  15. Vergnes B, Gourbal B, Girard I, Sundar S, Drummelsmith J, Ouellette M. A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death. Mol Cell Proteomics. 2007;6:88–101
  16. Leprohon P, Légaré D, Raymond F, Madore E, Hardiman G, Corbeil J, et al. Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum. Nucleic Acids Res. 2009;37:1387–1399
  17. Singh N, Singh RT, Sundar S. Novel mechanism of drug resistance in kala azar field isolates. J Infect Dis. 2003;188:600–607
  18. Srividya G, Duncan R, Sharma P, Raju BVS, Nakhasi HL, Salotra P. Transcriptome analysis during the process of in vitro differentiation of Leishmania donovani using genomic microarrays. Parasitology. 2007;134:1527–1539
  19. Papadopoulou B, Roy G, Ouellette M. A novel antifolate resistance gene on the amplified H circle of Leishmania. EMBO J. 1992;11:3601–3608
  20. Salotra P, Duncan RC, Singh R, Subba Raju BV, Sreenivas G, Nakhasi HL. Upregulation of surface proteins in Leishmania donovani isolated from patients of post kala-azar dermal leishmaniasis. Microbes Infect. 2006;8:637–644
  21. Ubeda JM, Légaré D, Raymond F, Ouameur AA, Boisvert S, Rigault P, et al. Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy. Genome Biol. 2008;9:R115
  22. Kuhn D, Wiese M. LmxPK4, a mitogen-activated protein kinase homologue of Leishmania mexicana with a potential role in parasite differentiation. Mol Microbiol. 2005;56:1169–1182
  23. Parsons M, Worthey EA, Ward PN, Mottram JC. Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi. BMC Genomics. 2005;6:127
  24. Wiese M. A mitogen-activated protein (MAP) kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host. EMBO J. 1998;17:2619–2628
  25. Wang Q, Melzer IM, Kruse M, Sander-Juelch C, Wiese M. LmxMPK4, a mitogen-activated protein (MAP) kinase homologue essential for promastigotes and amastigotes of Leishmania mexicana. Kinetoplastid Biol Dis. 2005;4:6
  26. Erdmann M, Scholz A, Melzer IM, Schmetz C, Wiese M. Interacting protein kinases involved in the regulation of flagellar length. Mol Biol Cell. 2006;17:2035–2045
  27. Bengs F, Scholz A, Kuhn D, Wiese M. LmxMPK9, a mitogen-activated protein kinase homologue affects flagellar length in Leishmania mexicana. Mol Microbiol. 2005;55:1606–1615
  28. Soto M, Requena JM, Gomez LC, Navarrete I, Alonso C. Molecular characterization of a Leishmania donovani infantum antigen identified as histone H2A. Eur J Biochem. 1992;205:211–216
  29. Soto M, Quijada L, Alonso C, Requena JM. Molecular cloning and analysis of expression of the Leishmania infantum histone H4 genes. Mol Biochem Parasitol. 1997;90:439–447
  30. Fasel NJ, Robyr DC, Mauel J, Glaser TA. Identification of a histone H1-like gene expressed in Leishmania major. Mol Biochem Parasitol. 1993;62:321–323
  31. Martínez E, Thomas MC, Alonso V, Carmelo E, González AC, Del Castillo A, et al. Cloning and molecular characterization of the cDNA encoding histone H1 from Leishmania braziliensis. J Parasitol. 2002;88:199–203
  32. Papageorgiou FT, Soteriadou KP. Expression of a novel Leishmania gene encoding a histone H1-like protein in Leishmania major modulates parasite infectivity in vitro. Infect Immun. 2002;70:6976–6986
  33. Abanades DR, Ramírez L, Iborra S, Soteriadou K, González VM, Bonay P, et al. Key role of the 3’ untranslated region in the cell cycle regulated expression of the Leishmania infantum histone H2A genes: minor synergistic effect of the 5’ untranslated region. BMC Mol Biol. 2009;10:48
  34. Thomas S, Green A, Sturm NR, Campbell DA, Myler PJ. Histone acetylations mark origins of polycistronic transcription in Leishmania major. BMC Genomics. 2009;10:152
  35. Smirlis D, Bisti SN, Xingi E, Konidou G, Thiakaki M, Soteriadou KP. Leishmania histone H1 overexpression delays parasite cell-cycle progression, parasite differentiation and reduces Leishmania infectivity in vivo. Mol Microbiol. 2006;60:1457–1473
  36. Masina S, Zangger H, Rivier D, Fasel N. Histone H1 regulates chromatin condensation in Leishmania parasites. Exp Parasitol. 2007;116:83–87
  37. Soto M, Requena JM, Moreira D, Alonso C. Organization, transcription and regulation of the Leishmania infantum histone H3 genes. Biochem J. 1996;18:813–819
  38. Choudhury K, Zander D, Kube M, Reinhardt R, Clos J. Identification of a Leishmania infantum gene mediating resistance to miltefosine and SbIII. Int J Parasitol. 2008;38:1411–1423

PII: S0924-8579(10)00145-7

doi: 10.1016/j.ijantimicag.2010.03.012

International Journal of Antimicrobial Agents
Volume 36, Issue 1 , Pages 50-57 , July 2010

Article Tools

* Image Usage & Resolution